In 2019, drug resistant microbial infections claimed more than 1.3 million lives, and over the next 25 years, it is expected that more people will die from drug resistant infections than from cancer. New antimicrobials and alternatives to traditional chemotherapeutic agents are urgently needed to treat infections that are resistant to all current therapies, alongside […]
Charting a path to clean air: A community-centred approach to active travel policy
Greater Manchester has amongst the worst air quality in the UK. Air pollution causes many health problems, as well as worsening pre-existing health conditions. Increasingly, Greater Manchester residents are concerned about poor air quality and want actions to be taken. Yet, budgets that could support change are under more and more constraints. In this article, […]
Out of mind? What policymakers should learn from those who shielded from COVID-19
Between the beginning of the COVID-19 pandemic and September 2021, 4.1 million people in the UK were asked to ‘shield’, including those with autoimmune conditions such as rheumatoid arthritis. Shielding recommendations included staying at home, avoiding all face-to-face contact with those outside shielders’ households, and limiting interactions within households. Here, Dr Charlotte Sharp and Lynn […]
Advancing cell and gene therapies: Levelling-up life sciences investment in the North-West
Life sciences – including new cancer treatments – forms a central pillar of the UK Government’s post-Brexit plan for science and technology. But how could this focus also play a role in another key tenet of British policymaking; the levelling-up agenda? In this blog, adapted from our On Cancer publication, Professor Fiona Thistlethwaite and Professor […]
Access and inclusion: Can we move cancer services closer to home?
Traditionally, the vast majority of cancer services take place in hospitals, but new thinking and new technology are rapidly changing this landscape, particularly because of the impact of COVID-19 on the delivery of healthcare services. In this blog, from our On Cancer publication, Dr Philip Crosbie and Dr Dónal Landers outlines how delivering services at […]
Disadvantage and disease: finding solutions to inequalities in cancer
The COVID-19 pandemic has brought renewed focus to the great health inequalities between different communities in our society. Looking at cancer care, these inequalities exist across the whole cancer pathway from uptake in screening, likelihood to present early with symptoms, participation in clinical trials, diagnosis and access to treatments. In this blog, from our On […]
Too close to the sun: The health benefits and economic case for banning sunbeds
Melanoma skin cancers are the UK’s fifth most common cancer, causing over 2,000 deaths each year. Over 85% of cases are preventable, with excessive exposure to ultraviolet light the most common cause, including the ultraviolet light used in sunbeds. The cancer risk from sunbeds is well known, but a new study has outlined the stark […]
Making light work: Recommendations for healthy lighting
Light exposure has important effects on human health and wellbeing, regulating our sleep/wake cycles, and influencing our mental and physical health. Advances in our understanding of the role of light in health, and emerging lighting technologies, now present opportunities to adjust lighting to promote optimal physical and mental health and performance. In this blog, Professor […]
Antifungal resistance – a growing global problem
The spread of resistance to antifungal medications has led to many serious infections becoming untreatable, compromising patient safety and posing a global public health threat. The World Health Organisation (WHO) will soon publish its fungal pathogen priority list, highlighting fungi that are already untreatable, and those for which treatment outcomes are poor. In this blog, […]
Rapid diagnosis and treatment of fungal infections
The rapid and accurate diagnosis of fungal infections is crucial to effective treatment and ultimately saves lives. Diagnostics are often not widely available in low income countries leading to inappropriate and delayed treatments. This is the case for a serious fungal infection called chronic pulmonary aspergillosis (CPA), and often for other fungal infections associated with […]